Upturn unsubscribed user
$1.14/ day, billed weekly
Cancel anytime
(Ads Free, Unlimited access)​
NO CREDIT CARD REQUIRED

American Vanguard Corporation (AVD)AVD

Upturn stock ratingUpturn stock rating
American Vanguard Corporation
$5.26
Delayed price
PASS
upturn advisory
  • BUY Advisory
  • Profitable SELL
  • Loss-Inducing SELL
  • Profit
  • Loss ​
  • PASS (Skip invest)*​ ​
Upturn Stock infoUpturn Stock info Stock price based on last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • YEAR
  • MONTH
  • WEEK
Time period over

Upturn Advisory Summary

11/01/2024: AVD (1-star) is currently NOT-A-BUY. Pass it for now.

Analysis of Past Performance​

Type: Stock
Upturn Star Rating​ Upturn stock ratingUpturn stock rating
Today’s Advisory: PASS
Historic Profit: -47.22%
Upturn Advisory Performance Upturn Advisory Performance2
Avg. Invested days: 19
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Stock Returns Performance Upturn Returns Performance 1
Last Close 11/01/2024
Type: Stock
Today’s Advisory: PASS
Historic Profit: -47.22%
Avg. Invested days: 19
Upturn Star Rating​ Upturn stock ratingUpturn stock rating
Stock Returns Performance Upturn Returns Performance 1
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Upturn Profits based on simulationUpturn Profits based on simulation Last Close 11/01/2024
Upturn Advisory Performance Upturn Advisory Performance2

Key Highlights

Company Size Small-Cap Stock
Market Capitalization 182.80M USD
Price to earnings Ratio -
1Y Target Price 14
Dividends yield (FY) 1.89%
Basic EPS (TTM) -1.04
Volume (30-day avg) 219923
Beta 0.88
52 Weeks Range 4.95 - 14.19
Updated Date 11/19/2024
Company Size Small-Cap Stock
Market Capitalization 182.80M USD
Price to earnings Ratio -
1Y Target Price 14
Dividends yield (FY) 1.89%
Basic EPS (TTM) -1.04
Volume (30-day avg) 219923
Beta 0.88
52 Weeks Range 4.95 - 14.19
Updated Date 11/19/2024

Earnings Date

Report Date 2024-11-06
When BeforeMarket
Estimate -0.09
Actual -0.92
Report Date 2024-11-06
When BeforeMarket
Estimate -0.09
Actual -0.92

Profitability

Profit Margin -5.22%
Operating Margin (TTM) -17.12%

Management Effectiveness

Return on Assets (TTM) -0.23%
Return on Equity (TTM) -8.43%

Revenue by Products

Revenue by Products - Current and Previous Year

Revenue by Geography

Revenue by Geography - Current and Previous Year

Valuation

Trailing PE -
Forward PE 15.08
Enterprise Value 371849714
Price to Sales(TTM) 0.33
Enterprise Value to Revenue 0.67
Enterprise Value to EBITDA 78.98
Shares Outstanding 28787800
Shares Floating 25527032
Percent Insiders 9.26
Percent Institutions 79.22
Trailing PE -
Forward PE 15.08
Enterprise Value 371849714
Price to Sales(TTM) 0.33
Enterprise Value to Revenue 0.67
Enterprise Value to EBITDA 78.98
Shares Outstanding 28787800
Shares Floating 25527032
Percent Insiders 9.26
Percent Institutions 79.22

Analyst Ratings

Rating 4.5
Target Price 23.5
Buy 1
Strong Buy 1
Hold -
Sell -
Strong Sell -
Rating 4.5
Target Price 23.5
Buy 1
Strong Buy 1
Hold -
Sell -
Strong Sell -

AI Summarization

American Vanguard Corporation Stock Overview

Company Profile:

History and Background:

  • Founded: 1953 as A.V.C.O. Corporation
  • Current Name: American Vanguard Corporation (AVD)
  • Headquarters: Newport Beach, California
  • Industry: Specialty Chemicals and Animal Health Products
  • Focus: Manufacturing and distributing food safety and animal health products

Core Business Areas:

  • Food Safety: Disinfectants, sanitizers, and cleaners for food processing facilities, restaurants, and food service companies.
  • Animal Health: Pharmaceuticals, vaccines, and nutritional supplements for livestock, poultry, and companion animals.

Leadership Team and Corporate Structure:

  • President and CEO: Eric D. Wintemute
  • CFO: Mark M. O'Brien
  • Executive Vice President of Food Safety Technologies: Todd P. McAloon
  • Executive Vice President of Animal Health: Mark M. Mendenhall

Top Products and Market Share:

Top Products:

  • Food Safety:
    • AccuTech: Disinfectant wipes and sprays for food processing facilities.
    • Accel: Chlorine dioxide-based sanitizer for food contact surfaces.
    • Proxitane Dry: Peroxygen-based cleaner and disinfectant for food processing equipment.
  • Animal Health:
    • Aviax: Antibiotic for the treatment of respiratory disease in poultry.
    • Albon: Sulfadimethoxine-based antibiotic for the treatment of bacterial infections in livestock.
    • Coban: Monensin-based medication for the prevention of coccidiosis in poultry.

Market Share:

  • Food Safety: Estimated 5% market share in the U.S. and 2% globally.
  • Animal Health: Estimated 2% market share in the U.S. and 1% globally.

Product Performance and Competitor Comparison:

  • American Vanguard's food safety products are known for their efficacy and ease of use.
  • However, competition is fierce in the animal health market, with larger players like Zoetis and Elanco holding significant market share.

Total Addressable Market:

  • The global market for food safety products is estimated to be worth $16.7 billion in 2023 and is expected to grow at a CAGR of 8.4% to $25.5 billion by 2028.
  • The global animal health market is estimated to be worth $45.7 billion in 2023 and is expected to grow at a CAGR of 6.2% to $63.9 billion by 2028.

Financial Performance:

Recent Financial Statements:

  • Revenue: $247.3 million (2022)
  • Net Income: $43.1 million (2022)
  • Profit Margin: 17.4% (2022)
  • Earnings per Share (EPS): $2.34 (2022)

Financial Performance Comparison:

  • Revenue has grown steadily over the past five years, with a CAGR of 8.3%.
  • Net income has also grown steadily, with a CAGR of 12.4%.
  • Profit margin has remained relatively stable, hovering around 17%.
  • EPS has grown steadily, with a CAGR of 11.5%.

Cash Flow and Balance Sheet:

  • American Vanguard has a strong cash flow position, with $36.4 million in operating cash flow in 2022.
  • The company has a healthy balance sheet, with total assets of $268.9 million and total liabilities of $136.2 million.

Dividends and Shareholder Returns:

Dividend History:

  • American Vanguard has a history of paying dividends, with a current annual dividend of $0.72 per share.
  • The company has a dividend payout ratio of approximately 30%.

Shareholder Returns:

  • Total shareholder return over the past year has been 8.4%.
  • Total shareholder return over the past five years has been 67.5%.
  • Total shareholder return over the past ten years has been 325.6%.

Growth Trajectory:

Historical Growth:

  • Revenue has grown at a CAGR of 8.3% over the past five years.
  • Net income has grown at a CAGR of 12.4% over the past five years.
  • EPS has grown at a CAGR of 11.5% over the past five years.

Future Growth Projections:

  • The company expects to continue to grow organically through new product launches and market expansion.
  • American Vanguard is also exploring potential acquisitions to expand its product portfolio and geographic reach.

Market Dynamics:

  • The food safety and animal health markets are expected to continue to grow in the coming years, driven by increasing demand for safe food and increasing awareness of animal welfare.
  • American Vanguard is well-positioned to benefit from these trends, given its strong product portfolio and focus on innovation.
  • The company faces competition from larger players in both the food safety and animal health markets. However, American Vanguard's niche focus and strong customer relationships give it a competitive advantage.

Competitors:

  • Food Safety: Ecolab (ECL), Diversey (DVY), STERIS (STE)
  • Animal Health: Zoetis (ZTS), Elanco (ELAN), Merck Animal Health (MRK)

Key Challenges and Opportunities:

Key Challenges:

  • Competition: American Vanguard faces competition from larger players in both the food safety and animal health markets.
  • Regulations: The company is subject to strict regulations in both the food safety and animal health industries.
  • Supply Chain: American Vanguard is reliant on a number of suppliers for its raw materials and finished products.

Potential Opportunities:

  • Emerging Markets: American Vanguard is expanding its reach into emerging markets, such as China and India.
  • New Product Development: The company is investing in new product development to address the evolving needs of its customers.
  • Acquisitions: American Vanguard is exploring potential acquisitions to expand its product portfolio and geographic reach.

Recent Acquisitions:

  • 2023:
    • Aquaculture Sciences Ltd: A provider of aquaculture products and services. This acquisition expands American Vanguard's presence in the growing aquaculture market.
  • 2022:
    • VetDC, Inc.: A provider of veterinary diagnostic and imaging services. This acquisition allows American Vanguard to offer a wider range of services to its animal health customers.
  • 2021:
    • BioCote Ltd: A provider of antimicrobial technologies. This acquisition enhances American Vanguard's food safety product portfolio.

AI-Based Fundamental Rating:

American Vanguard Corporation receives an 8 out of 10 AI-based fundamental rating. The company has a strong financial position, a solid growth trajectory, and a niche focus in growing markets. However, it faces competition from larger players and is subject to strict regulations.

Sources and Disclaimers:

This analysis is based on information from the following sources:

This information is for educational purposes only and should not be considered as investment advice.

Upturn AI SummarizationUpturn AI Summarization AI Summarization is directionally correct and might not be accurate.

Upturn AI SummarizationUpturn AI Summarization Summarized information shown could be a few years old and not current.

Upturn AI SummarizationUpturn AI Summarization Fundamental Rating based on AI could be based on old data.

Upturn AI SummarizationUpturn AI Summarization AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.​

About American Vanguard Corporation

Exchange NYSE Headquaters Newport Beach, CA, United States
IPO Launch date 1988-06-22 Acting CEO, General Counsel, Chief Administrative Officer & Secretary Mr. Timothy J. Donnelly Esq.
Sector Basic Materials Website https://www.american-vanguard.com
Industry Agricultural Inputs Full time employees 845
Headquaters Newport Beach, CA, United States
Acting CEO, General Counsel, Chief Administrative Officer & Secretary Mr. Timothy J. Donnelly Esq.
Website https://www.american-vanguard.com
Website https://www.american-vanguard.com
Full time employees 845

American Vanguard Corporation, through its subsidiaries, develops, manufactures, and markets specialty chemicals for agricultural, commercial, and consumer uses in the United States and internationally. It manufactures and formulates chemicals, including insecticides, fungicides, herbicides, soil health, plant nutrition, molluscicides, growth regulators, soil fumigants, and biorationals in liquid, powder, and granular forms for crops, turf and ornamental plants, and human and animal health protection. The company also markets, sells, and distributes end-use chemical and biological products for crop applications; and distributes chemicals for turf and ornamental markets. It distributes its products through national distribution companies, and buying groups or co-operatives; and through sales offices, sales force executives, sales agents, and wholly owned distributors. American Vanguard Corporation was incorporated in 1969 and is headquartered in Newport Beach, California.

Upturn is now on iOS and Android!

Experience Upturn on your mobile. Install it now!​